|
US6465016B2
(en)
*
|
1996-08-22 |
2002-10-15 |
Research Triangle Pharmaceuticals |
Cyclosporiine particles
|
|
US6182712B1
(en)
|
1997-07-21 |
2001-02-06 |
Inhale Therapeutic Systems |
Power filling apparatus and methods for their use
|
|
AU6283299A
(en)
*
|
1998-10-01 |
2000-04-17 |
Elan Pharma International Limited |
Controlled release nanoparticulate compositions
|
|
US20080213378A1
(en)
*
|
1998-10-01 |
2008-09-04 |
Elan Pharma International, Ltd. |
Nanoparticulate statin formulations and novel statin combinations
|
|
US8293277B2
(en)
*
|
1998-10-01 |
2012-10-23 |
Alkermes Pharma Ireland Limited |
Controlled-release nanoparticulate compositions
|
|
SK288117B6
(en)
*
|
1998-11-20 |
2013-09-03 |
Skyepharma Canada Inc. |
Rapidly dispersing solid dry therapeutic dosage form
|
|
FR2795961B1
(en)
*
|
1999-07-09 |
2004-05-28 |
Ethypharm Lab Prod Ethiques |
PHARMACEUTICAL COMPOSITION CONTAINING MICRONIZED FENOFIBRATE, A SURFACTANT AND A BINDING CELLULOSIC DERIVATIVE AND PREPARATION METHOD
|
|
US7863331B2
(en)
*
|
1999-07-09 |
2011-01-04 |
Ethypharm |
Pharmaceutical composition containing fenofibrate and method for the preparation thereof
|
|
US8586094B2
(en)
*
|
2000-09-20 |
2013-11-19 |
Jagotec Ag |
Coated tablets
|
|
US7198795B2
(en)
|
2000-09-21 |
2007-04-03 |
Elan Pharma International Ltd. |
In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate of nanoparticulate active agent compositions
|
|
US20030224058A1
(en)
*
|
2002-05-24 |
2003-12-04 |
Elan Pharma International, Ltd. |
Nanoparticulate fibrate formulations
|
|
US7276249B2
(en)
|
2002-05-24 |
2007-10-02 |
Elan Pharma International, Ltd. |
Nanoparticulate fibrate formulations
|
|
US20080241070A1
(en)
*
|
2000-09-21 |
2008-10-02 |
Elan Pharma International Ltd. |
Fenofibrate dosage forms
|
|
US7049146B2
(en)
|
2000-11-14 |
2006-05-23 |
Facet Analytical Services And Technology, Llc |
Calibration standards, methods, and kits for water determination
|
|
US7122376B2
(en)
*
|
2001-11-01 |
2006-10-17 |
Facet Analytical Services And Technology, Llc |
Calibration standards, methods, and kits for water determination
|
|
GB0028429D0
(en)
*
|
2000-11-22 |
2001-01-10 |
Astrazeneca Ab |
Therapy
|
|
US6951656B2
(en)
|
2000-12-22 |
2005-10-04 |
Baxter International Inc. |
Microprecipitation method for preparing submicron suspensions
|
|
US7193084B2
(en)
|
2000-12-22 |
2007-03-20 |
Baxter International Inc. |
Polymorphic form of itraconazole
|
|
US9700866B2
(en)
|
2000-12-22 |
2017-07-11 |
Baxter International Inc. |
Surfactant systems for delivery of organic compounds
|
|
US8067032B2
(en)
|
2000-12-22 |
2011-11-29 |
Baxter International Inc. |
Method for preparing submicron particles of antineoplastic agents
|
|
US6977085B2
(en)
|
2000-12-22 |
2005-12-20 |
Baxter International Inc. |
Method for preparing submicron suspensions with polymorph control
|
|
US6607784B2
(en)
|
2000-12-22 |
2003-08-19 |
Baxter International Inc. |
Microprecipitation method for preparing submicron suspensions
|
|
US6884436B2
(en)
|
2000-12-22 |
2005-04-26 |
Baxter International Inc. |
Method for preparing submicron particle suspensions
|
|
MXPA04002446A
(en)
|
2001-09-26 |
2004-07-23 |
Baxter Int |
Preparation of submicron sized nanoparticles via dispersion and solvent or liquid phase removal.
|
|
US20060003012A9
(en)
|
2001-09-26 |
2006-01-05 |
Sean Brynjelsen |
Preparation of submicron solid particle suspensions by sonication of multiphase systems
|
|
US7112340B2
(en)
|
2001-10-19 |
2006-09-26 |
Baxter International Inc. |
Compositions of and method for preparing stable particles in a frozen aqueous matrix
|
|
WO2003088951A1
(en)
*
|
2002-04-15 |
2003-10-30 |
Eiffel Technologies Limited |
Formulation of fine particles using liquefied or dense gases
|
|
NO346970B1
(en)
*
|
2002-05-24 |
2023-03-20 |
Alkermes Pharma Ireland Ltd |
Nanoparticulate fiber formulations
|
|
US20070264348A1
(en)
*
|
2002-05-24 |
2007-11-15 |
Elan Pharma International, Ltd. |
Nanoparticulate fibrate formulations
|
|
CA2488499C
(en)
*
|
2002-06-10 |
2013-03-19 |
Elan Pharma International Ltd. |
Nanoparticulate formulations comprising hmg coa reductase inhibitor derivatives ("statins"),combinations thereof as well as manufacturing of these pharmaceutical compositions
|
|
TW200404544A
(en)
*
|
2002-06-17 |
2004-04-01 |
Kowa Co |
Controlled release pharmaceutical composition
|
|
EP1515890B1
(en)
*
|
2002-06-27 |
2012-07-11 |
Novartis AG |
Device and method for controlling the flow of a powder
|
|
RS20050532A
(en)
|
2003-01-14 |
2007-12-31 |
Arena Pharmaceuticals Inc., |
1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prpphylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
|
|
EP1631496B1
(en)
|
2003-04-28 |
2014-02-26 |
Medical Instill Technologies, Inc. |
Container with valve assembly for filling and dispensing substances, and apparatus and method for filling
|
|
US20040241252A1
(en)
*
|
2003-05-29 |
2004-12-02 |
Abney Christopher Charles |
Pharmaceutical compositions for oral administration comprising lithium carbonate, processes of making the same, and methods of administering the same
|
|
KR20060056944A
(en)
|
2003-07-14 |
2006-05-25 |
아레나 파마슈티칼스, 인크. |
Prevention or treatment of aryl and heteroaryl derivatives fused as metabolic modulators and related disorders
|
|
US20050096391A1
(en)
*
|
2003-10-10 |
2005-05-05 |
Per Holm |
Compositions comprising fenofibrate and rosuvastatin
|
|
US9173847B2
(en)
*
|
2003-10-10 |
2015-11-03 |
Veloxis Pharmaceuticals A/S |
Tablet comprising a fibrate
|
|
CA2541382A1
(en)
*
|
2003-10-10 |
2005-04-21 |
Lifecycle Pharma A/S |
A solid dosage form comprising a fibrate and a statin
|
|
US20050096390A1
(en)
*
|
2003-10-10 |
2005-05-05 |
Per Holm |
Compositions comprising fenofibrate and pravastatin
|
|
KR20060085686A
(en)
*
|
2003-10-10 |
2006-07-27 |
라이프사이클 파마 에이/에스 |
Solid Formulations Containing Fibrate
|
|
US7390504B2
(en)
*
|
2003-11-07 |
2008-06-24 |
Jj Pharma, Inc. |
HDL-boosting combination therapy complexes
|
|
WO2005095950A1
(en)
*
|
2004-03-30 |
2005-10-13 |
Pfizer Products Inc. |
Method and device for evaluation of pharmaceutical compositions
|
|
DE602005005033T2
(en)
*
|
2004-03-30 |
2009-03-19 |
Smithkline Beecham Corp. |
SPRAY-DRIED PHARMACEUTICAL COMPOSITIONS
|
|
US7101585B2
(en)
*
|
2004-04-15 |
2006-09-05 |
Solae, Llc |
Ultra high pressure homogenization process for making a stable protein based acid beverage
|
|
US7306562B1
(en)
*
|
2004-04-23 |
2007-12-11 |
Medical Software, Llc |
Medical risk assessment method and program product
|
|
GB0411502D0
(en)
*
|
2004-05-22 |
2004-06-23 |
Britannia Pharmaceuticals Ltd |
Pharmaceutical compositions
|
|
US20060057216A1
(en)
*
|
2004-09-15 |
2006-03-16 |
Salamone Joseph C |
Low-obscuration image transmitting particulate ocular therapeutic formulations
|
|
US20060057215A1
(en)
*
|
2004-09-15 |
2006-03-16 |
Raiche Adrian T |
Method for the production of nanoparticles and microparticles by ternary agent concentration and temperature alteration induced immiscibility
|
|
US7495052B2
(en)
*
|
2004-09-15 |
2009-02-24 |
Bausch & Lomb Incorporated |
Method for the production of polymerized nanoparticles and microparticles by ternary agent concentration and temperature alteration induced immiscibility
|
|
CA2582403A1
(en)
*
|
2004-10-01 |
2006-04-13 |
Lifecycle Pharma A/S |
Pharmaceutical compositions comprising fenofibrate and atorvastatin
|
|
WO2006037346A1
(en)
*
|
2004-10-01 |
2006-04-13 |
Lifecycle Pharma A/S |
Pharmaceutical compositions comprising fenofibrate and simvastatin
|
|
JP2008521878A
(en)
*
|
2004-12-02 |
2008-06-26 |
ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー |
Pharmaceutical composition of amorphous atorvastatin and process for its production
|
|
KR20070104447A
(en)
*
|
2005-02-10 |
2007-10-25 |
라이프사이클 파마 에이/에스 |
Stable pharmaceutical composition comprising a fixed dose combination of fenofibrate and a HMV-COA reductase inhibitor
|
|
DE102005011786A1
(en)
*
|
2005-03-11 |
2006-09-14 |
Pharmasol Gmbh |
Process for preparing ultrafine submicron suspensions
|
|
US20060223882A1
(en)
*
|
2005-03-23 |
2006-10-05 |
Venkataraman Sundaram |
Amorphous simvastatin
|
|
CA2600407A1
(en)
*
|
2005-03-30 |
2006-10-12 |
Teva Pharmaceutical Industries Ltd. |
Fibrate compositions containing a surfactant mixture of peg-600 and poloxamer 407
|
|
CA2601372A1
(en)
*
|
2005-03-30 |
2006-10-12 |
Teva Pharmaceutical Industries Ltd. |
Improved formulations of fenofibrate containing menthol or peg/poloxamer
|
|
US20070148233A1
(en)
*
|
2005-12-28 |
2007-06-28 |
Lerner E I |
Pharmaceutical formulations of fenofibrate having improved bioavailability
|
|
WO2006084475A2
(en)
*
|
2005-04-13 |
2006-08-17 |
Lifecycle Pharma A/S |
A tablet comprising a fibrate
|
|
US20070015834A1
(en)
*
|
2005-07-18 |
2007-01-18 |
Moshe Flashner-Barak |
Formulations of fenofibrate containing PEG/Poloxamer
|
|
US20070015833A1
(en)
*
|
2005-07-18 |
2007-01-18 |
Moshe Flashner-Barak |
Formulations of fenofibrate containing menthol
|
|
CA2628666A1
(en)
*
|
2005-11-21 |
2007-05-24 |
Teva Pharmaceutical Industries Ltd. |
Atorvastatin formulation
|
|
EP1808162A1
(en)
*
|
2005-11-21 |
2007-07-18 |
Teva Pharmaceutical Industries Ltd. |
Atorvastatin pharmaceutical formulation
|
|
US20070148245A1
(en)
*
|
2005-12-22 |
2007-06-28 |
Ilan Zalit |
Compressed solid dosage forms with drugs of low solubility and process for making the same
|
|
WO2007075171A1
(en)
*
|
2005-12-28 |
2007-07-05 |
Teva Pharmaceutical Industries Ltd. |
Pharmaceutical formulations of fenofibrate having improved bioavailability
|
|
ES2325450T3
(en)
*
|
2005-12-28 |
2009-09-04 |
Teva Pharmaceutical Industries Ltd |
PHARMACEUTICAL PHENOFIBRATE FORMULATIONS WITH IMPROVED BIODISPONIBILITY
|
|
EP1905424A3
(en)
*
|
2006-02-02 |
2008-04-30 |
Ranbaxy Laboratories Limited |
Process for the preparation of a pharmaceutical composition comprising stabilized statin particles
|
|
WO2007100609A2
(en)
*
|
2006-02-24 |
2007-09-07 |
Albert Einstein College Of Medicine Of Yeshiva University |
Electron transfer through glassy matrices
|
|
WO2007127286A2
(en)
|
2006-04-24 |
2007-11-08 |
Medical Instill Technologies, Inc. |
Needle penetrable and laser resealable lyophilization device and related method
|
|
EP1870649A1
(en)
|
2006-06-20 |
2007-12-26 |
Octapharma AG |
Lyophilisation targetting defined residual moisture by limited desorption energy levels
|
|
AU2007265452A1
(en)
*
|
2006-06-26 |
2008-01-03 |
Mutual Pharmaceutical Company, Inc. |
Active agent formulations, methods of making, and methods of use
|
|
US7877895B2
(en)
*
|
2006-06-26 |
2011-02-01 |
Tokyo Electron Limited |
Substrate processing apparatus
|
|
GB0613925D0
(en)
*
|
2006-07-13 |
2006-08-23 |
Unilever Plc |
Improvements relating to nanodispersions
|
|
BRPI0715423A2
(en)
*
|
2006-07-21 |
2013-07-02 |
Novartis Ag |
formulations for benzimidazolyl pyridyl ethers
|
|
KR20090027734A
(en)
*
|
2006-07-27 |
2009-03-17 |
(주)아모레퍼시픽 |
Method for preparing a powder containing nanoparticles of poorly soluble drugs
|
|
US20080132560A1
(en)
*
|
2006-11-21 |
2008-06-05 |
San-Laung Chow |
Solid dispersion composition
|
|
WO2008065502A1
(en)
*
|
2006-11-29 |
2008-06-05 |
Pfizer Products Inc. |
Pharmaceutical compositions based on a) nanoparticles comprising enteric polymers and b) casein
|
|
US7908765B2
(en)
*
|
2006-12-22 |
2011-03-22 |
Collette Nv |
Continuous granulating and drying apparatus
|
|
US20080161594A1
(en)
*
|
2006-12-29 |
2008-07-03 |
Industrial Technology Research Institute |
Method for fabricating nanoparticles containing fenofibrate
|
|
US7872560B2
(en)
*
|
2007-03-19 |
2011-01-18 |
Abc Taiwan Electronics Corp. |
Independent planar transformer
|
|
US20100119612A1
(en)
*
|
2007-04-17 |
2010-05-13 |
Bend Research, Inc |
Nanoparticles comprising non-crystalline drug
|
|
US20100080852A1
(en)
*
|
2007-05-03 |
2010-04-01 |
Ronald Arthur Beyerinck |
Phamaceutical composition comprising nanoparticles and casein
|
|
WO2008135828A2
(en)
*
|
2007-05-03 |
2008-11-13 |
Pfizer Products Inc. |
Nanoparticles comprising a drug, ethylcellulose, and a bile salt
|
|
US8703204B2
(en)
*
|
2007-05-03 |
2014-04-22 |
Bend Research, Inc. |
Nanoparticles comprising a cholesteryl ester transfer protein inhibitor and anon-ionizable polymer
|
|
EP2162120B1
(en)
*
|
2007-06-04 |
2016-05-04 |
Bend Research, Inc |
Nanoparticles comprising a non-ionizable cellulosic polymer and an amphiphilic non-ionizable block copolymer
|
|
WO2008149230A2
(en)
|
2007-06-04 |
2008-12-11 |
Pfizer Products Inc. |
Nanoparticles comprising drug, a non-ionizable cellulosic polymer and tocopheryl polyethylene glycol succinate
|
|
US20100215747A1
(en)
*
|
2007-07-13 |
2010-08-26 |
Corey Jay Bloom |
Nanoparticles comprising ionizable, poorly water soluble cellulosic polymers
|
|
HRP20191104T1
(en)
|
2007-09-25 |
2019-09-20 |
Solubest Ltd. |
Compositions comprising lipophilic active compounds and method for their preparation
|
|
WO2009073215A1
(en)
*
|
2007-12-06 |
2009-06-11 |
Bend Research, Inc. |
Pharmaceutical compositions comprising nanoparticles and a resuspending material
|
|
EP2240162A4
(en)
*
|
2007-12-06 |
2013-10-09 |
Bend Res Inc |
NANOPARTICLES COMPRISING A NON-IONIZABLE POLYMER AND AN AMINO-FUNCTIONALIZED METHACRYLATE COPOLYMER
|
|
WO2009085766A2
(en)
*
|
2007-12-19 |
2009-07-09 |
Mutual Pharmaceutical Company, Inc. |
Fenofibric acid amorphous dispersion; method of making; and method of use thereof
|
|
US20090162434A1
(en)
*
|
2007-12-21 |
2009-06-25 |
Disphar International Bv |
Mesalazine tablet
|
|
US20100159010A1
(en)
*
|
2008-12-24 |
2010-06-24 |
Mutual Pharmaceutical Company, Inc. |
Active Agent Formulations, Methods of Making, and Methods of Use
|
|
PT3130396T
(en)
|
2009-03-27 |
2021-05-12 |
Bend Res Inc |
Spray-drying process
|
|
BRPI1006722A2
(en)
|
2009-04-09 |
2017-10-10 |
Entegrion Inc |
"method of preparing dehydrated blood products, dehydrated blood products, bandage or surgical aids, method for preparing dehydrated fixed blood platelets, dehydrated fixed blood platelets, method for treating a patient suffering from a blood disorder and dry fixed blood platelets" by atomization having geometry with spherical cavities "
|
|
US20110142885A1
(en)
|
2009-09-16 |
2011-06-16 |
Velico Medical, Inc. |
Spray-dried human plasma
|
|
KR100980749B1
(en)
|
2009-12-17 |
2010-09-07 |
삼일제약주식회사 |
Fenofibrate-containing granules and pharmaceutical composition comprising the same
|
|
WO2012031133A2
(en)
|
2010-09-03 |
2012-03-08 |
Bench Research, Inc. |
Spray-drying apparatus and methods of using the same
|
|
WO2012031129A2
(en)
|
2010-09-03 |
2012-03-08 |
Bend Research, Inc. |
Spray-drying apparatus and methods of using the same
|
|
CN103221410B
(en)
|
2010-09-22 |
2017-09-15 |
艾尼纳制药公司 |
GPR119 receptor modulators and treatment of disorders associated therewith
|
|
US9248584B2
(en)
|
2010-09-24 |
2016-02-02 |
Bend Research, Inc. |
High-temperature spray drying process and apparatus
|
|
US8877221B2
(en)
|
2010-10-27 |
2014-11-04 |
Warsaw Orthopedic, Inc. |
Osteoconductive matrices comprising calcium phosphate particles and statins and methods of using the same
|
|
US9107983B2
(en)
|
2010-10-27 |
2015-08-18 |
Warsaw Orthopedic, Inc. |
Osteoconductive matrices comprising statins
|
|
US9308190B2
(en)
|
2011-06-06 |
2016-04-12 |
Warsaw Orthopedic, Inc. |
Methods and compositions to enhance bone growth comprising a statin
|
|
KR20140147891A
(en)
|
2012-04-13 |
2014-12-30 |
글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드 |
Aggregate particles
|
|
US9439860B2
(en)
|
2012-06-25 |
2016-09-13 |
Mylan, Inc. |
Fenofibrate formulation
|
|
US8722083B2
(en)
|
2012-06-25 |
2014-05-13 |
Mylan, Inc. |
Fenofibrate formulation
|
|
MX2013006332A
(en)
*
|
2013-06-05 |
2014-12-19 |
Alparis Sa De Cv |
Oral pharmaceutical compositions for use in dyslipidemias.
|
|
EP2878311A1
(en)
*
|
2013-11-27 |
2015-06-03 |
Freund Pharmatec Ltd. |
Solubility Enhancement for Hydrophobic Drugs
|
|
EP3154528B1
(en)
|
2014-06-11 |
2023-04-05 |
SpecGx LLC |
Spray dried compositions having different dissolution profiles and processes for their preparation
|
|
US9561184B2
(en)
|
2014-09-19 |
2017-02-07 |
Velico Medical, Inc. |
Methods and systems for multi-stage drying of plasma
|
|
CA2962719A1
(en)
|
2014-10-31 |
2016-05-06 |
Bend Research Inc. |
Process for forming active domains dispersed in a matrix
|
|
CA3002540C
(en)
|
2015-01-06 |
2023-11-07 |
Arena Pharmaceuticals, Inc. |
Use of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid for treating conditions related to the s1p1 receptor
|
|
JP6838744B2
(en)
|
2015-06-22 |
2021-03-03 |
アリーナ ファーマシューティカルズ, インコーポレイテッド |
(R) -2- (7- (4-cyclopentyl-3- (trifluoromethyl) benzyloxy) -1,2,3,4-tetrahydrocyclopenta [b] indole-for use in S1P1 receptor-related disorders Crystalline L-arginine salt of 3-yl) acetic acid (Compound 1)
|
|
CN110520124A
(en)
|
2017-02-16 |
2019-11-29 |
艾尼纳制药公司 |
For treating the Compounds and methods for of primary biliary cholangitis
|
|
US10627161B2
(en)
*
|
2018-01-24 |
2020-04-21 |
King Abdulaziz City for Science and Technology (KACST) |
Laboratory equipment and method of using the same for drying a starting material to produce nano material
|
|
JP7397011B2
(en)
|
2018-06-06 |
2023-12-12 |
アリーナ ファーマシューティカルズ, インコーポレイテッド |
Methods of treating conditions associated with S1P1 receptors
|
|
WO2022183281A1
(en)
*
|
2021-03-03 |
2022-09-09 |
Mcmaster Christopher R |
Compounds and treatments for muscular dystrophy
|
|
US20220313678A1
(en)
*
|
2021-04-06 |
2022-10-06 |
Altria Client Services Llc |
Spray dried nicotine for inclusion in oral products
|
|
USD1081739S1
(en)
|
2021-04-06 |
2025-07-01 |
Altria Client Services Llc |
Die for gum forming
|
|
US12246266B2
(en)
|
2022-09-15 |
2025-03-11 |
Velico Medical, Inc. |
Disposable for a spray drying system
|
|
US12539355B2
(en)
*
|
2022-09-15 |
2026-02-03 |
Velico Medical, Inc. |
Dryer for a spray drying system
|
|
US12246093B2
(en)
|
2022-09-15 |
2025-03-11 |
Velico Medical, Inc. |
Methods for making spray dried plasma
|
|
US11998861B2
(en)
|
2022-09-15 |
2024-06-04 |
Velico Medical, Inc. |
Usability of a disposable for a spray drying plasma system
|
|
US11841189B1
(en)
|
2022-09-15 |
2023-12-12 |
Velico Medical, Inc. |
Disposable for a spray drying system
|
|
US11975274B2
(en)
|
2022-09-15 |
2024-05-07 |
Velico Medical, Inc. |
Blood plasma product
|
|
US12083447B2
(en)
|
2022-09-15 |
2024-09-10 |
Velico Medical, Inc. |
Alignment of a disposable for a spray drying plasma system
|
|
WO2024059770A1
(en)
|
2022-09-15 |
2024-03-21 |
Velico Medical, Inc. |
Rapid spray drying system
|
|
US12571587B2
(en)
*
|
2022-09-15 |
2026-03-10 |
Velico Medical, Inc. |
Finishing apparatus for a spray drying system
|